Structure based on 3qkl

Ideal structure
Name: n-{(2s)-3-[(3s)-8',9'-dihydro-1h,3'h-spiro[piperidine-3,7'-pyrano[3,2-e]indazol]-1-yl]-2-hydroxypropyl}-n-(2-ethoxyethyl)-2,6-dimethylbenzenesulfonamide
Formula: C29 H40 N4 O5 S
Weight: 556.717
SMILES: "CCOCCN(C[CH](O)CN1CCC[C]2(CCc3c(O2)ccc4[nH]ncc34)C1)[S](=O)(=O)c5c(C)cccc5C"
Spacial conformation based on PDB 3qkl
RESIDUE   SMR     79
CONECT      C1     4 C2   C5   O6   C10 
CONECT      C2     4 C1   C3   H2   H2A 
CONECT      C3     4 C2   C4   H3   H3A 
CONECT      C4     4 C3   N39  H4   H4A 
CONECT      C5     4 C1   N39  H5   H5A 
CONECT      O6     2 C1   C7  
CONECT      C7     3 O6   C8   C11 
CONECT      C8     3 C7   C9   C14 
CONECT      C9     4 C8   C10  H9   H9A 
CONECT      C10    4 C1   C9   H10  H10A
CONECT      C11    3 C7   C12  H11 
CONECT      C12    3 C11  C13  H12 
CONECT      C13    3 C12  C14  N15 
CONECT      C14    3 C8   C13  C17 
CONECT      N15    3 C13  N16  HN15
CONECT      N16    2 N15  C17 
CONECT      C17    3 C14  N16  H17 
CONECT      C18    4 C19  N39  H18  H18A
CONECT      C19    4 C18  C20  O21  H19 
CONECT      C20    4 C19  N22  H20  H20A
CONECT      O21    2 C19  HO21
CONECT      N22    3 C20  C23  S36 
CONECT      C23    4 N22  C24  H23  H23A
CONECT      C24    4 C23  O33  H24  H24A
CONECT      C25    3 C26  C30  S36 
CONECT      C26    3 C25  C27  C32 
CONECT      C27    3 C26  C28  H27 
CONECT      C28    3 C27  C29  H28 
CONECT      C29    3 C28  C30  H29 
CONECT      C30    3 C25  C29  C31 
CONECT      C31    4 C30  H31  H31A H31B
CONECT      C32    4 C26  H32  H32A H32B
CONECT      O33    2 C24  C35 
CONECT      C34    4 C35  H34  H34A H34B
CONECT      C35    4 O33  C34  H35  H35A
CONECT      S36    4 N22  C25  O37  O38 
CONECT      O37    1 S36 
CONECT      O38    1 S36 
CONECT      N39    3 C4   C5   C18 
CONECT      H2     1 C2  
CONECT      H2A    1 C2  
CONECT      H3     1 C3  
CONECT      H3A    1 C3  
CONECT      H4     1 C4  
CONECT      H4A    1 C4  
CONECT      H5     1 C5  
CONECT      H5A    1 C5  
CONECT      H9     1 C9  
CONECT      H9A    1 C9  
CONECT      H10    1 C10 
CONECT      H10A   1 C10 
CONECT      H11    1 C11 
CONECT      H12    1 C12 
CONECT      H17    1 C17 
CONECT      H18    1 C18 
CONECT      H18A   1 C18 
CONECT      H19    1 C19 
CONECT      H20    1 C20 
CONECT      H20A   1 C20 
CONECT      HO21   1 O21 
CONECT      H23    1 C23 
CONECT      H23A   1 C23 
CONECT      H24    1 C24 
CONECT      H24A   1 C24 
CONECT      H27    1 C27 
CONECT      H28    1 C28 
CONECT      H29    1 C29 
CONECT      H31    1 C31 
CONECT      H31A   1 C31 
CONECT      H31B   1 C31 
CONECT      H32    1 C32 
CONECT      H32A   1 C32 
CONECT      H32B   1 C32 
CONECT      H34    1 C34 
CONECT      H34A   1 C34 
CONECT      H34B   1 C34 
CONECT      H35    1 C35 
CONECT      H35A   1 C35 
CONECT      HN15   1 N15 
END   
HET    SMR             79
HETNAM     SMR N-{(2S)-3-[(3S)-8',9'-dihydro-1H,3'H-spiro[piperidine-3
HETNAM   2 SMR ,7'-pyrano[3,2-e]indazol]-1-yl]-2-hydroxypropyl}-N-(2-e
HETNAM   3 SMR thoxyethyl)-2,6-dimethylbenzenesulfonamide
FORMUL      SMR    C29 H40 N4 O5 S1

This OCA MONOMER page
uses Jmol, developed by the Jmol Development Team (color reference)
OCA© by Jaime Prilusky, 1996-2004,2006,2010,2014
Bioinformatics Unit
Weizmann Institute of Science